Dr. Christopher Wilson

Dr. Christopher Wilson has extensive work experience in the healthcare, medical device, and life sciences industries. Dr. Christopher has held various leadership positions in different companies. Dr. Wilson has served as the Director of Business Development and Operations at AQPHA Medical BV, where they were responsible for overseeing various operations, including finance, supply chain, HR, manufacturing, and regulatory compliance. Dr. Christopher has also worked as the Managing Director at Listerdale Life Sciences BV, providing investment and consultancy services to start-up companies in the medical space. Dr. Wilson has experience in strategic new business development and has raised significant funding for early-stage companies. Dr. Christopher has also been a Partner at WMC Group LLC and an Expert Reviewer at the European Research Executive Agency (REA). Additionally, Dr. Wilson has served as the Clinical Director at Parkinson Smartwatch and Commercial Director at Meds2go, where they played key roles in clinical consulting, revenue growth, and business development. Dr. Christopher has also held positions as the Director of Programs at Holland US Bridge, Consultant at Whale Bay & Co, and CEO & Founder of NovioSense BV, where they led the growth and operations of the company and successfully raised multiple rounds of venture-backed financing. Dr. Christopher Wilson is currently a Board Member at Sensible Healthcare Systems.

Dr. Christopher Wilson has a diverse education history. Dr. Christopher obtained a PhD in Advanced Organic Materials as well as a Doctor of Philosophy (PhD) in Advanced Materials from the University of Hull from 2004 to 2007. Prior to that, they completed their undergraduate studies in Chemistry Drug Design and Toxicology, earning an MChem degree from the University of Hull from 2000 to 2004.

In terms of additional certifications, Dr. Wilson has obtained various qualifications. Dr. Christopher completed Health Economics and Policy training at The London School of Economics and Political Science (LSE) in 2022. Dr. Christopher also completed several Coursera courses, including Epidemiology in Public Health Practice Specialization, Clinical Epidemiology, Design and Interpretation of Clinical Trials, and Economics of Health Care Delivery, all in 2022. Furthermore, they have certifications in ISO 19011:2018 Management System Auditor Training and Internal audit on Medical Device QMS - ISO 13485:2016 from Udemy, obtained in 2023. Additionally, they received the Good Clinical Practice certification from Brookwood Global in 2017, and they became a Fellow of the Royal Society of Chemistry in December 2021.